▶ 調査レポート

僧帽弁閉鎖不全症のグローバル市場インサイト・予測(~2028年)

• 英文タイトル:Global Mitral Regurgitation Market Insights, Forecast to 2028

QYResearchが調査・発行した産業分析レポートです。僧帽弁閉鎖不全症のグローバル市場インサイト・予測(~2028年) / Global Mitral Regurgitation Market Insights, Forecast to 2028 / QY2203B11741資料のイメージです。• レポートコード:QY2203B11741
• 出版社/出版日:QYResearch / 2022年3月25日
• レポート形態:英文、PDF、125ページ
• 納品方法:Eメール(納期:3日)
• 産業分類:医療
• 販売価格(消費税別)
  Single User¥661,500 (USD4,900)▷ お問い合わせ
  Multi User¥992,250 (USD7,350)▷ お問い合わせ
  Enterprise License¥1,323,000 (USD9,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
新型コロナウイルス感染症のパンデミックにより、世界の僧帽弁閉鎖不全症の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx%で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に僧帽弁閉鎖不全症の世界市場のxxx%を占める「一次性僧帽弁閉鎖不全症」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx%CAGRで成長すると予測されています。一方、「経皮的」セグメントは、この予測期間を通じてxxx%のCAGRに変更されます。
中国の僧帽弁閉鎖不全症の市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの僧帽弁閉鎖不全症市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx%であり、中国とヨーロッパはそれぞれxxx%とxxx%です。中国の割合は2028年にxxx%に達し、対象期間を通じてxxx%のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx%、xxx%、xxx%になる見通しです。ヨーロッパの僧帽弁閉鎖不全症市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx%になる見通しです。

僧帽弁閉鎖不全症のグローバル主要メーカーには、Edwards Lifesciences、Abbott、CardioSolution、NeoChord、Mitralign、Medtronic、Boston Scientific、Mitralix、Shanghai Hanyu Medical Technology、Valgen Holding Corporation、NeoChord、CoreMedic、Babic Chord、Gore Medical、Valtech Cardio、Transcardiac、ChoRe、AVVIE、Cardiovalve、HighLife SAS、Neovasc、MitrAssist Lifesciences、Shanghai NewMed Medical、Peijia Medical、MicroPort CardioFlow Medtechなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx%の市場シェアを占めています。

僧帽弁閉鎖不全症市場は、種類と用途によって区分されます。世界の僧帽弁閉鎖不全症市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年~2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
一次性僧帽弁閉鎖不全症、二次性僧帽弁閉鎖不全症

【用途別セグメント】
経皮的、株間的、右内頚静脈的

【掲載地域】
北米:アメリカ、カナダ
ヨーロッパ:ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋:日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米:メキシコ、ブラジル、アルゼンチン
中東・アフリカ:トルコ、サウジアラビア、UAE

【目次(一部)】

・調査の範囲
- 僧帽弁閉鎖不全症製品概要
- 種類別市場(一次性僧帽弁閉鎖不全症、二次性僧帽弁閉鎖不全症)
- 用途別市場(経皮的、株間的、右内頚静脈的)
- 調査の目的
・エグゼクティブサマリー
- 世界の僧帽弁閉鎖不全症販売量予測2017-2028
- 世界の僧帽弁閉鎖不全症売上予測2017-2028
- 僧帽弁閉鎖不全症の地域別販売量
- 僧帽弁閉鎖不全症の地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別僧帽弁閉鎖不全症販売量
- 主要メーカー別僧帽弁閉鎖不全症売上
- 主要メーカー別僧帽弁閉鎖不全症価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模(一次性僧帽弁閉鎖不全症、二次性僧帽弁閉鎖不全症)
- 僧帽弁閉鎖不全症の種類別販売量
- 僧帽弁閉鎖不全症の種類別売上
- 僧帽弁閉鎖不全症の種類別価格
・用途別市場規模(経皮的、株間的、右内頚静脈的)
- 僧帽弁閉鎖不全症の用途別販売量
- 僧帽弁閉鎖不全症の用途別売上
- 僧帽弁閉鎖不全症の用途別価格
・北米市場
- 北米の僧帽弁閉鎖不全症市場規模(種類別、用途別)
- 主要国別の僧帽弁閉鎖不全症市場規模(アメリカ、カナダ)
・ヨーロッパ市場
- ヨーロッパの僧帽弁閉鎖不全症市場規模(種類別、用途別)
- 主要国別の僧帽弁閉鎖不全症市場規模(ドイツ、フランス、イギリス、イタリア、ロシア)
・アジア太平洋市場
- アジア太平洋の僧帽弁閉鎖不全症市場規模(種類別、用途別)
- 主要国別の僧帽弁閉鎖不全症市場規模(日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア)
・中南米市場
- 中南米の僧帽弁閉鎖不全症市場規模(種類別、用途別)
- 主要国別の僧帽弁閉鎖不全症市場規模(メキシコ、ブラジル、アルゼンチン)
・中東・アフリカ市場
- 中東・アフリカの僧帽弁閉鎖不全症市場規模(種類別、用途別)
- 主要国別の僧帽弁閉鎖不全症市場規模(トルコ、サウジアラビア)
・企業情報
Edwards Lifesciences、Abbott、CardioSolution、NeoChord、Mitralign、Medtronic、Boston Scientific、Mitralix、Shanghai Hanyu Medical Technology、Valgen Holding Corporation、NeoChord、CoreMedic、Babic Chord、Gore Medical、Valtech Cardio、Transcardiac、ChoRe、AVVIE、Cardiovalve、HighLife SAS、Neovasc、MitrAssist Lifesciences、Shanghai NewMed Medical、Peijia Medical、MicroPort CardioFlow Medtech
・産業チェーン及び販売チャネル分析
- 僧帽弁閉鎖不全症の産業チェーン分析
- 僧帽弁閉鎖不全症の原材料
- 僧帽弁閉鎖不全症の生産プロセス
- 僧帽弁閉鎖不全症の販売及びマーケティング
- 僧帽弁閉鎖不全症の主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- 僧帽弁閉鎖不全症の産業動向
- 僧帽弁閉鎖不全症のマーケットドライバー
- 僧帽弁閉鎖不全症の課題
- 僧帽弁閉鎖不全症の阻害要因
・主な調査結果

Mitral regurgitation (MR) is the backflow of blood from the left ventricle into the left atrium during left ventricular systole. The mitral valve is located in the opening between the left atrium and the left ventricle. It opens to allow blood from the left atrium to fill the left ventricle. When the left ventricle contracts, the mitral valve closes so that pumped blood can only flow into the aorta. When the mitral valve is not fully closed, some blood can leak back into the left atrium. Mitral regurgitation can be divided into primary and secondary MR according to the pathogenesis. Primary mitral regurgitation is due to the pathological changes of one or more of the mitral valve leaflets, valve annulus, chordae tendineae and papillary muscles, such as degenerative disease or rheumatic disease, which cause the mitral valve to fail to close normally. Secondary mitral valve regurgitation is functional mitral valve regurgitation, which is caused by the disease of the heart itself or the valve supporting structure, such as pathological changes of the myocardium leading to pathological dilatation of the left ventricle and mitral valve annulus or Mitral regurgitation due to localized displacement of the left ventricle and subvalvular device. The current quantitative assessment of mitral valve regurgitation, the current standards of various guidelines and documents are not completely consistent, generally divided into mild, moderate and severe, this classification is relatively broad, can not well reflect the changes and manifestations before and after surgery effect of surgery. In the MitraClip system clinical trial, mitral regurgitation was divided into no (0+), mild (1+), moderate (2+), moderate to severe (3+), severe (4+), and then more This classification method is used in several clinical studies of mitral valve regurgitation interventional therapy.
Market Analysis and Insights: Global Mitral Regurgitation Market
The global Mitral Regurgitation market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, Primary Mitral Regurgitation accounting for % of the Mitral Regurgitation global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Transapical segment is altered to an % CAGR throughout this forecast period.
China Mitral Regurgitation market size is valued at US$ million in 2021, while the North America and Europe Mitral Regurgitation are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Mitral Regurgitation landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Mitral Regurgitation market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Mitral Regurgitation market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Mitral Regurgitation market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Mitral Regurgitation market.
Global Mitral Regurgitation Scope and Market Size
Mitral Regurgitation market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Mitral Regurgitation market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Primary Mitral Regurgitation
Secondary Mitral Regurgitation
Segment by Application
Transapical
Via Stock and Via Interstitial
Right Internal Jugular Vein
By Company
Edwards Lifesciences
Abbott
CardioSolution
NeoChord
Mitralign
Medtronic
Boston Scientific
Mitralix
Shanghai Hanyu Medical Technology
Valgen Holding Corporation
NeoChord
CoreMedic
Babic Chord
Gore Medical
Valtech Cardio
Transcardiac
ChoRe
AVVIE
Cardiovalve
HighLife SAS
Neovasc
MitrAssist Lifesciences
Shanghai NewMed Medical
Peijia Medical
MicroPort CardioFlow Medtech
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

レポート目次

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Mitral Regurgitation Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Primary Mitral Regurgitation
1.2.3 Secondary Mitral Regurgitation
1.3 Market by Application
1.3.1 Global Mitral Regurgitation Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Transapical
1.3.3 Via Stock and Via Interstitial
1.3.4 Right Internal Jugular Vein
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Mitral Regurgitation Market Perspective (2017-2028)
2.2 Mitral Regurgitation Growth Trends by Region
2.2.1 Mitral Regurgitation Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Mitral Regurgitation Historic Market Size by Region (2017-2022)
2.2.3 Mitral Regurgitation Forecasted Market Size by Region (2023-2028)
2.3 Mitral Regurgitation Market Dynamics
2.3.1 Mitral Regurgitation Industry Trends
2.3.2 Mitral Regurgitation Market Drivers
2.3.3 Mitral Regurgitation Market Challenges
2.3.4 Mitral Regurgitation Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Mitral Regurgitation Players by Revenue
3.1.1 Global Top Mitral Regurgitation Players by Revenue (2017-2022)
3.1.2 Global Mitral Regurgitation Revenue Market Share by Players (2017-2022)
3.2 Global Mitral Regurgitation Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Mitral Regurgitation Revenue
3.4 Global Mitral Regurgitation Market Concentration Ratio
3.4.1 Global Mitral Regurgitation Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Mitral Regurgitation Revenue in 2021
3.5 Mitral Regurgitation Key Players Head office and Area Served
3.6 Key Players Mitral Regurgitation Product Solution and Service
3.7 Date of Enter into Mitral Regurgitation Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Mitral Regurgitation Breakdown Data by Type
4.1 Global Mitral Regurgitation Historic Market Size by Type (2017-2022)
4.2 Global Mitral Regurgitation Forecasted Market Size by Type (2023-2028)
5 Mitral Regurgitation Breakdown Data by Application
5.1 Global Mitral Regurgitation Historic Market Size by Application (2017-2022)
5.2 Global Mitral Regurgitation Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Mitral Regurgitation Market Size (2017-2028)
6.2 North America Mitral Regurgitation Market Size by Type
6.2.1 North America Mitral Regurgitation Market Size by Type (2017-2022)
6.2.2 North America Mitral Regurgitation Market Size by Type (2023-2028)
6.2.3 North America Mitral Regurgitation Market Share by Type (2017-2028)
6.3 North America Mitral Regurgitation Market Size by Application
6.3.1 North America Mitral Regurgitation Market Size by Application (2017-2022)
6.3.2 North America Mitral Regurgitation Market Size by Application (2023-2028)
6.3.3 North America Mitral Regurgitation Market Share by Application (2017-2028)
6.4 North America Mitral Regurgitation Market Size by Country
6.4.1 North America Mitral Regurgitation Market Size by Country (2017-2022)
6.4.2 North America Mitral Regurgitation Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Mitral Regurgitation Market Size (2017-2028)
7.2 Europe Mitral Regurgitation Market Size by Type
7.2.1 Europe Mitral Regurgitation Market Size by Type (2017-2022)
7.2.2 Europe Mitral Regurgitation Market Size by Type (2023-2028)
7.2.3 Europe Mitral Regurgitation Market Share by Type (2017-2028)
7.3 Europe Mitral Regurgitation Market Size by Application
7.3.1 Europe Mitral Regurgitation Market Size by Application (2017-2022)
7.3.2 Europe Mitral Regurgitation Market Size by Application (2023-2028)
7.3.3 Europe Mitral Regurgitation Market Share by Application (2017-2028)
7.4 Europe Mitral Regurgitation Market Size by Country
7.4.1 Europe Mitral Regurgitation Market Size by Country (2017-2022)
7.4.2 Europe Mitral Regurgitation Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Mitral Regurgitation Market Size (2017-2028)
8.2 Asia-Pacific Mitral Regurgitation Market Size by Type
8.2.1 Asia-Pacific Mitral Regurgitation Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Mitral Regurgitation Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Mitral Regurgitation Market Share by Type (2017-2028)
8.3 Asia-Pacific Mitral Regurgitation Market Size by Application
8.3.1 Asia-Pacific Mitral Regurgitation Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Mitral Regurgitation Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Mitral Regurgitation Market Share by Application (2017-2028)
8.4 Asia-Pacific Mitral Regurgitation Market Size by Region
8.4.1 Asia-Pacific Mitral Regurgitation Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Mitral Regurgitation Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Mitral Regurgitation Market Size (2017-2028)
9.2 Latin America Mitral Regurgitation Market Size by Type
9.2.1 Latin America Mitral Regurgitation Market Size by Type (2017-2022)
9.2.2 Latin America Mitral Regurgitation Market Size by Type (2023-2028)
9.2.3 Latin America Mitral Regurgitation Market Share by Type (2017-2028)
9.3 Latin America Mitral Regurgitation Market Size by Application
9.3.1 Latin America Mitral Regurgitation Market Size by Application (2017-2022)
9.3.2 Latin America Mitral Regurgitation Market Size by Application (2023-2028)
9.3.3 Latin America Mitral Regurgitation Market Share by Application (2017-2028)
9.4 Latin America Mitral Regurgitation Market Size by Country
9.4.1 Latin America Mitral Regurgitation Market Size by Country (2017-2022)
9.4.2 Latin America Mitral Regurgitation Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Mitral Regurgitation Market Size (2017-2028)
10.2 Middle East & Africa Mitral Regurgitation Market Size by Type
10.2.1 Middle East & Africa Mitral Regurgitation Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Mitral Regurgitation Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Mitral Regurgitation Market Share by Type (2017-2028)
10.3 Middle East & Africa Mitral Regurgitation Market Size by Application
10.3.1 Middle East & Africa Mitral Regurgitation Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Mitral Regurgitation Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Mitral Regurgitation Market Share by Application (2017-2028)
10.4 Middle East & Africa Mitral Regurgitation Market Size by Country
10.4.1 Middle East & Africa Mitral Regurgitation Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Mitral Regurgitation Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Edwards Lifesciences
11.1.1 Edwards Lifesciences Company Details
11.1.2 Edwards Lifesciences Business Overview
11.1.3 Edwards Lifesciences Mitral Regurgitation Introduction
11.1.4 Edwards Lifesciences Revenue in Mitral Regurgitation Business (2017-2022)
11.1.5 Edwards Lifesciences Recent Developments
11.2 Abbott
11.2.1 Abbott Company Details
11.2.2 Abbott Business Overview
11.2.3 Abbott Mitral Regurgitation Introduction
11.2.4 Abbott Revenue in Mitral Regurgitation Business (2017-2022)
11.2.5 Abbott Recent Developments
11.3 CardioSolution
11.3.1 CardioSolution Company Details
11.3.2 CardioSolution Business Overview
11.3.3 CardioSolution Mitral Regurgitation Introduction
11.3.4 CardioSolution Revenue in Mitral Regurgitation Business (2017-2022)
11.3.5 CardioSolution Recent Developments
11.4 NeoChord
11.4.1 NeoChord Company Details
11.4.2 NeoChord Business Overview
11.4.3 NeoChord Mitral Regurgitation Introduction
11.4.4 NeoChord Revenue in Mitral Regurgitation Business (2017-2022)
11.4.5 NeoChord Recent Developments
11.5 Mitralign
11.5.1 Mitralign Company Details
11.5.2 Mitralign Business Overview
11.5.3 Mitralign Mitral Regurgitation Introduction
11.5.4 Mitralign Revenue in Mitral Regurgitation Business (2017-2022)
11.5.5 Mitralign Recent Developments
11.6 Medtronic
11.6.1 Medtronic Company Details
11.6.2 Medtronic Business Overview
11.6.3 Medtronic Mitral Regurgitation Introduction
11.6.4 Medtronic Revenue in Mitral Regurgitation Business (2017-2022)
11.6.5 Medtronic Recent Developments
11.7 Boston Scientific
11.7.1 Boston Scientific Company Details
11.7.2 Boston Scientific Business Overview
11.7.3 Boston Scientific Mitral Regurgitation Introduction
11.7.4 Boston Scientific Revenue in Mitral Regurgitation Business (2017-2022)
11.7.5 Boston Scientific Recent Developments
11.8 Mitralix
11.8.1 Mitralix Company Details
11.8.2 Mitralix Business Overview
11.8.3 Mitralix Mitral Regurgitation Introduction
11.8.4 Mitralix Revenue in Mitral Regurgitation Business (2017-2022)
11.8.5 Mitralix Recent Developments
11.9 Shanghai Hanyu Medical Technology
11.9.1 Shanghai Hanyu Medical Technology Company Details
11.9.2 Shanghai Hanyu Medical Technology Business Overview
11.9.3 Shanghai Hanyu Medical Technology Mitral Regurgitation Introduction
11.9.4 Shanghai Hanyu Medical Technology Revenue in Mitral Regurgitation Business (2017-2022)
11.9.5 Shanghai Hanyu Medical Technology Recent Developments
11.10 Valgen Holding Corporation
11.10.1 Valgen Holding Corporation Company Details
11.10.2 Valgen Holding Corporation Business Overview
11.10.3 Valgen Holding Corporation Mitral Regurgitation Introduction
11.10.4 Valgen Holding Corporation Revenue in Mitral Regurgitation Business (2017-2022)
11.10.5 Valgen Holding Corporation Recent Developments
11.11 NeoChord
11.11.1 NeoChord Company Details
11.11.2 NeoChord Business Overview
11.11.3 NeoChord Mitral Regurgitation Introduction
11.11.4 NeoChord Revenue in Mitral Regurgitation Business (2017-2022)
11.11.5 NeoChord Recent Developments
11.12 CoreMedic
11.12.1 CoreMedic Company Details
11.12.2 CoreMedic Business Overview
11.12.3 CoreMedic Mitral Regurgitation Introduction
11.12.4 CoreMedic Revenue in Mitral Regurgitation Business (2017-2022)
11.12.5 CoreMedic Recent Developments
11.13 Babic Chord
11.13.1 Babic Chord Company Details
11.13.2 Babic Chord Business Overview
11.13.3 Babic Chord Mitral Regurgitation Introduction
11.13.4 Babic Chord Revenue in Mitral Regurgitation Business (2017-2022)
11.13.5 Babic Chord Recent Developments
11.14 Gore Medical
11.14.1 Gore Medical Company Details
11.14.2 Gore Medical Business Overview
11.14.3 Gore Medical Mitral Regurgitation Introduction
11.14.4 Gore Medical Revenue in Mitral Regurgitation Business (2017-2022)
11.14.5 Gore Medical Recent Developments
11.15 Valtech Cardio
11.15.1 Valtech Cardio Company Details
11.15.2 Valtech Cardio Business Overview
11.15.3 Valtech Cardio Mitral Regurgitation Introduction
11.15.4 Valtech Cardio Revenue in Mitral Regurgitation Business (2017-2022)
11.15.5 Valtech Cardio Recent Developments
11.16 Transcardiac
11.16.1 Transcardiac Company Details
11.16.2 Transcardiac Business Overview
11.16.3 Transcardiac Mitral Regurgitation Introduction
11.16.4 Transcardiac Revenue in Mitral Regurgitation Business (2017-2022)
11.16.5 Transcardiac Recent Developments
11.17 ChoRe
11.17.1 ChoRe Company Details
11.17.2 ChoRe Business Overview
11.17.3 ChoRe Mitral Regurgitation Introduction
11.17.4 ChoRe Revenue in Mitral Regurgitation Business (2017-2022)
11.17.5 ChoRe Recent Developments
11.18 AVVIE
11.18.1 AVVIE Company Details
11.18.2 AVVIE Business Overview
11.18.3 AVVIE Mitral Regurgitation Introduction
11.18.4 AVVIE Revenue in Mitral Regurgitation Business (2017-2022)
11.18.5 AVVIE Recent Developments
11.19 Cardiovalve
11.19.1 Cardiovalve Company Details
11.19.2 Cardiovalve Business Overview
11.19.3 Cardiovalve Mitral Regurgitation Introduction
11.19.4 Cardiovalve Revenue in Mitral Regurgitation Business (2017-2022)
11.19.5 Cardiovalve Recent Developments
11.20 HighLife SAS
11.20.1 HighLife SAS Company Details
11.20.2 HighLife SAS Business Overview
11.20.3 HighLife SAS Mitral Regurgitation Introduction
11.20.4 HighLife SAS Revenue in Mitral Regurgitation Business (2017-2022)
11.20.5 HighLife SAS Recent Developments
11.21 Neovasc
11.21.1 Neovasc Company Details
11.21.2 Neovasc Business Overview
11.21.3 Neovasc Mitral Regurgitation Introduction
11.21.4 Neovasc Revenue in Mitral Regurgitation Business (2017-2022)
11.21.5 Neovasc Recent Developments
11.22 MitrAssist Lifesciences
11.22.1 MitrAssist Lifesciences Company Details
11.22.2 MitrAssist Lifesciences Business Overview
11.22.3 MitrAssist Lifesciences Mitral Regurgitation Introduction
11.22.4 MitrAssist Lifesciences Revenue in Mitral Regurgitation Business (2017-2022)
11.22.5 MitrAssist Lifesciences Recent Developments
11.23 Shanghai NewMed Medical
11.23.1 Shanghai NewMed Medical Company Details
11.23.2 Shanghai NewMed Medical Business Overview
11.23.3 Shanghai NewMed Medical Mitral Regurgitation Introduction
11.23.4 Shanghai NewMed Medical Revenue in Mitral Regurgitation Business (2017-2022)
11.23.5 Shanghai NewMed Medical Recent Developments
11.24 Peijia Medical
11.24.1 Peijia Medical Company Details
11.24.2 Peijia Medical Business Overview
11.24.3 Peijia Medical Mitral Regurgitation Introduction
11.24.4 Peijia Medical Revenue in Mitral Regurgitation Business (2017-2022)
11.24.5 Peijia Medical Recent Developments
11.25 MicroPort CardioFlow Medtech
11.25.1 MicroPort CardioFlow Medtech Company Details
11.25.2 MicroPort CardioFlow Medtech Business Overview
11.25.3 MicroPort CardioFlow Medtech Mitral Regurgitation Introduction
11.25.4 MicroPort CardioFlow Medtech Revenue in Mitral Regurgitation Business (2017-2022)
11.25.5 MicroPort CardioFlow Medtech Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

List of Tables
Table 1. Global Mitral Regurgitation Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Primary Mitral Regurgitation
Table 3. Key Players of Secondary Mitral Regurgitation
Table 4. Global Mitral Regurgitation Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 5. Global Mitral Regurgitation Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Mitral Regurgitation Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global Mitral Regurgitation Market Share by Region (2017-2022)
Table 8. Global Mitral Regurgitation Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global Mitral Regurgitation Market Share by Region (2023-2028)
Table 10. Mitral Regurgitation Market Trends
Table 11. Mitral Regurgitation Market Drivers
Table 12. Mitral Regurgitation Market Challenges
Table 13. Mitral Regurgitation Market Restraints
Table 14. Global Mitral Regurgitation Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global Mitral Regurgitation Revenue Share by Players (2017-2022)
Table 16. Global Top Mitral Regurgitation by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mitral Regurgitation as of 2021)
Table 17. Ranking of Global Top Mitral Regurgitation Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by Mitral Regurgitation Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Mitral Regurgitation Product Solution and Service
Table 21. Date of Enter into Mitral Regurgitation Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Mitral Regurgitation Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global Mitral Regurgitation Revenue Market Share by Type (2017-2022)
Table 25. Global Mitral Regurgitation Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global Mitral Regurgitation Revenue Market Share by Type (2023-2028)
Table 27. Global Mitral Regurgitation Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global Mitral Regurgitation Revenue Share by Application (2017-2022)
Table 29. Global Mitral Regurgitation Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global Mitral Regurgitation Revenue Share by Application (2023-2028)
Table 31. North America Mitral Regurgitation Market Size by Type (2017-2022) & (US$ Million)
Table 32. North America Mitral Regurgitation Market Size by Type (2023-2028) & (US$ Million)
Table 33. North America Mitral Regurgitation Market Size by Application (2017-2022) & (US$ Million)
Table 34. North America Mitral Regurgitation Market Size by Application (2023-2028) & (US$ Million)
Table 35. North America Mitral Regurgitation Market Size by Country (2017-2022) & (US$ Million)
Table 36. North America Mitral Regurgitation Market Size by Country (2023-2028) & (US$ Million)
Table 37. Europe Mitral Regurgitation Market Size by Type (2017-2022) & (US$ Million)
Table 38. Europe Mitral Regurgitation Market Size by Type (2023-2028) & (US$ Million)
Table 39. Europe Mitral Regurgitation Market Size by Application (2017-2022) & (US$ Million)
Table 40. Europe Mitral Regurgitation Market Size by Application (2023-2028) & (US$ Million)
Table 41. Europe Mitral Regurgitation Market Size by Country (2017-2022) & (US$ Million)
Table 42. Europe Mitral Regurgitation Market Size by Country (2023-2028) & (US$ Million)
Table 43. Asia Pacific Mitral Regurgitation Market Size by Type (2017-2022) & (US$ Million)
Table 44. Asia Pacific Mitral Regurgitation Market Size by Type (2023-2028) & (US$ Million)
Table 45. Asia Pacific Mitral Regurgitation Market Size by Application (2017-2022) & (US$ Million)
Table 46. Asia Pacific Mitral Regurgitation Market Size by Application (2023-2028) & (US$ Million)
Table 47. Asia Pacific Mitral Regurgitation Market Size by Region (2017-2022) & (US$ Million)
Table 48. Asia Pacific Mitral Regurgitation Market Size by Region (2023-2028) & (US$ Million)
Table 49. Latin America Mitral Regurgitation Market Size by Type (2017-2022) & (US$ Million)
Table 50. Latin America Mitral Regurgitation Market Size by Type (2023-2028) & (US$ Million)
Table 51. Latin America Mitral Regurgitation Market Size by Application (2017-2022) & (US$ Million)
Table 52. Latin America Mitral Regurgitation Market Size by Application (2023-2028) & (US$ Million)
Table 53. Latin America Mitral Regurgitation Market Size by Country (2017-2022) & (US$ Million)
Table 54. Latin America Mitral Regurgitation Market Size by Country (2023-2028) & (US$ Million)
Table 55. Middle East and Africa Mitral Regurgitation Market Size by Type (2017-2022) & (US$ Million)
Table 56. Middle East and Africa Mitral Regurgitation Market Size by Type (2023-2028) & (US$ Million)
Table 57. Middle East and Africa Mitral Regurgitation Market Size by Application (2017-2022) & (US$ Million)
Table 58. Middle East and Africa Mitral Regurgitation Market Size by Application (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Mitral Regurgitation Market Size by Country (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Mitral Regurgitation Market Size by Country (2023-2028) & (US$ Million)
Table 61. Edwards Lifesciences Company Details
Table 62. Edwards Lifesciences Business Overview
Table 63. Edwards Lifesciences Mitral Regurgitation Product
Table 64. Edwards Lifesciences Revenue in Mitral Regurgitation Business (2017-2022) & (US$ Million)
Table 65. Edwards Lifesciences Recent Developments
Table 66. Abbott Company Details
Table 67. Abbott Business Overview
Table 68. Abbott Mitral Regurgitation Product
Table 69. Abbott Revenue in Mitral Regurgitation Business (2017-2022) & (US$ Million)
Table 70. Abbott Recent Developments
Table 71. CardioSolution Company Details
Table 72. CardioSolution Business Overview
Table 73. CardioSolution Mitral Regurgitation Product
Table 74. CardioSolution Revenue in Mitral Regurgitation Business (2017-2022) & (US$ Million)
Table 75. CardioSolution Recent Developments
Table 76. NeoChord Company Details
Table 77. NeoChord Business Overview
Table 78. NeoChord Mitral Regurgitation Product
Table 79. NeoChord Revenue in Mitral Regurgitation Business (2017-2022) & (US$ Million)
Table 80. NeoChord Recent Developments
Table 81. Mitralign Company Details
Table 82. Mitralign Business Overview
Table 83. Mitralign Mitral Regurgitation Product
Table 84. Mitralign Revenue in Mitral Regurgitation Business (2017-2022) & (US$ Million)
Table 85. Mitralign Recent Developments
Table 86. Medtronic Company Details
Table 87. Medtronic Business Overview
Table 88. Medtronic Mitral Regurgitation Product
Table 89. Medtronic Revenue in Mitral Regurgitation Business (2017-2022) & (US$ Million)
Table 90. Medtronic Recent Developments
Table 91. Boston Scientific Company Details
Table 92. Boston Scientific Business Overview
Table 93. Boston Scientific Mitral Regurgitation Product
Table 94. Boston Scientific Revenue in Mitral Regurgitation Business (2017-2022) & (US$ Million)
Table 95. Boston Scientific Recent Developments
Table 96. Mitralix Company Details
Table 97. Mitralix Business Overview
Table 98. Mitralix Mitral Regurgitation Product
Table 99. Mitralix Revenue in Mitral Regurgitation Business (2017-2022) & (US$ Million)
Table 100. Mitralix Recent Developments
Table 101. Shanghai Hanyu Medical Technology Company Details
Table 102. Shanghai Hanyu Medical Technology Business Overview
Table 103. Shanghai Hanyu Medical Technology Mitral Regurgitation Product
Table 104. Shanghai Hanyu Medical Technology Revenue in Mitral Regurgitation Business (2017-2022) & (US$ Million)
Table 105. Shanghai Hanyu Medical Technology Recent Developments
Table 106. Valgen Holding Corporation Company Details
Table 107. Valgen Holding Corporation Business Overview
Table 108. Valgen Holding Corporation Mitral Regurgitation Product
Table 109. Valgen Holding Corporation Revenue in Mitral Regurgitation Business (2017-2022) & (US$ Million)
Table 110. Valgen Holding Corporation Recent Developments
Table 111. NeoChord Company Details
Table 112. NeoChord Business Overview
Table 113. NeoChord Mitral Regurgitation Product
Table 114. NeoChord Revenue in Mitral Regurgitation Business (2017-2022) & (US$ Million)
Table 115. NeoChord Recent Developments
Table 116. CoreMedic Company Details
Table 117. CoreMedic Business Overview
Table 118. CoreMedic Mitral Regurgitation Product
Table 119. CoreMedic Revenue in Mitral Regurgitation Business (2017-2022) & (US$ Million)
Table 120. CoreMedic Recent Developments
Table 121. Babic Chord Company Details
Table 122. Babic Chord Business Overview
Table 123. Babic Chord Mitral Regurgitation Product
Table 124. Babic Chord Revenue in Mitral Regurgitation Business (2017-2022) & (US$ Million)
Table 125. Babic Chord Recent Developments
Table 126. Gore Medical Company Details
Table 127. Gore Medical Business Overview
Table 128. Gore Medical Mitral Regurgitation Product
Table 129. Gore Medical Revenue in Mitral Regurgitation Business (2017-2022) & (US$ Million)
Table 130. Gore Medical Recent Developments
Table 131. Valtech Cardio Company Details
Table 132. Valtech Cardio Business Overview
Table 133. Valtech Cardio Mitral Regurgitation Product
Table 134. Valtech Cardio Revenue in Mitral Regurgitation Business (2017-2022) & (US$ Million)
Table 135. Valtech Cardio Recent Developments
Table 136. Transcardiac Company Details
Table 137. Transcardiac Business Overview
Table 138. Transcardiac Mitral Regurgitation Product
Table 139. Transcardiac Revenue in Mitral Regurgitation Business (2017-2022) & (US$ Million)
Table 140. Transcardiac Recent Developments
Table 141. ChoRe Company Details
Table 142. ChoRe Business Overview
Table 143. ChoRe Mitral Regurgitation Product
Table 144. ChoRe Revenue in Mitral Regurgitation Business (2017-2022) & (US$ Million)
Table 145. ChoRe Recent Developments
Table 146. AVVIE Company Details
Table 147. AVVIE Business Overview
Table 148. AVVIE Mitral Regurgitation Product
Table 149. AVVIE Revenue in Mitral Regurgitation Business (2017-2022) & (US$ Million)
Table 150. AVVIE Recent Developments
Table 151. Cardiovalve Company Details
Table 152. Cardiovalve Business Overview
Table 153. Cardiovalve Mitral Regurgitation Product
Table 154. Cardiovalve Revenue in Mitral Regurgitation Business (2017-2022) & (US$ Million)
Table 155. Cardiovalve Recent Developments
Table 156. HighLife SAS Company Details
Table 157. HighLife SAS Business Overview
Table 158. HighLife SAS Mitral Regurgitation Product
Table 159. HighLife SAS Revenue in Mitral Regurgitation Business (2017-2022) & (US$ Million)
Table 160. HighLife SAS Recent Developments
Table 161. Neovasc Company Details
Table 162. Neovasc Business Overview
Table 163. Neovasc Mitral Regurgitation Product
Table 164. Neovasc Revenue in Mitral Regurgitation Business (2017-2022) & (US$ Million)
Table 165. Neovasc Recent Developments
Table 166. MitrAssist Lifesciences Company Details
Table 167. MitrAssist Lifesciences Business Overview
Table 168. MitrAssist Lifesciences Mitral Regurgitation Product
Table 169. MitrAssist Lifesciences Revenue in Mitral Regurgitation Business (2017-2022) & (US$ Million)
Table 170. MitrAssist Lifesciences Recent Developments
Table 171. Shanghai NewMed Medical Company Details
Table 172. Shanghai NewMed Medical Business Overview
Table 173. Shanghai NewMed Medical Mitral Regurgitation Product
Table 174. Shanghai NewMed Medical Revenue in Mitral Regurgitation Business (2017-2022) & (US$ Million)
Table 175. Shanghai NewMed Medical Recent Developments
Table 176. Peijia Medical Company Details
Table 177. Peijia Medical Business Overview
Table 178. Peijia Medical Mitral Regurgitation Product
Table 179. Peijia Medical Revenue in Mitral Regurgitation Business (2017-2022) & (US$ Million)
Table 180. Peijia Medical Recent Developments
Table 181. MicroPort CardioFlow Medtech Company Details
Table 182. MicroPort CardioFlow Medtech Business Overview
Table 183. MicroPort CardioFlow Medtech Mitral Regurgitation Product
Table 184. MicroPort CardioFlow Medtech Revenue in Mitral Regurgitation Business (2017-2022) & (US$ Million)
Table 185. MicroPort CardioFlow Medtech Recent Developments
Table 186. Research Programs/Design for This Report
Table 187. Key Data Information from Secondary Sources
Table 188. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Mitral Regurgitation Market Share by Type: 2021 VS 2028
Figure 2. Primary Mitral Regurgitation Features
Figure 3. Secondary Mitral Regurgitation Features
Figure 4. Global Mitral Regurgitation Market Share by Application: 2021 VS 2028
Figure 5. Transapical Case Studies
Figure 6. Via Stock and Via Interstitial Case Studies
Figure 7. Right Internal Jugular Vein Case Studies
Figure 8. Mitral Regurgitation Report Years Considered
Figure 9. Global Mitral Regurgitation Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 10. Global Mitral Regurgitation Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Mitral Regurgitation Market Share by Region: 2021 VS 2028
Figure 12. Global Mitral Regurgitation Market Share by Players in 2021
Figure 13. Global Top Mitral Regurgitation Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mitral Regurgitation as of 2021)
Figure 14. The Top 10 and 5 Players Market Share by Mitral Regurgitation Revenue in 2021
Figure 15. North America Mitral Regurgitation Market Size YoY (2017-2028) & (US$ Million)
Figure 16. North America Mitral Regurgitation Market Size Market Share by Type (2017-2028)
Figure 17. North America Mitral Regurgitation Market Size Market Share by Application (2017-2028)
Figure 18. North America Mitral Regurgitation Market Size Share by Country (2017-2028)
Figure 19. United States Mitral Regurgitation Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Canada Mitral Regurgitation Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Europe Mitral Regurgitation Market Size YoY (2017-2028) & (US$ Million)
Figure 22. Europe Mitral Regurgitation Market Size Market Share by Type (2017-2028)
Figure 23. Europe Mitral Regurgitation Market Size Market Share by Application (2017-2028)
Figure 24. Europe Mitral Regurgitation Market Size Share by Country (2017-2028)
Figure 25. Germany Mitral Regurgitation Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. France Mitral Regurgitation Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. U.K. Mitral Regurgitation Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Italy Mitral Regurgitation Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Russia Mitral Regurgitation Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Nordic Countries Mitral Regurgitation Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Asia-Pacific Mitral Regurgitation Market Size YoY (2017-2028) & (US$ Million)
Figure 32. Asia Pacific Mitral Regurgitation Market Size Market Share by Type (2017-2028)
Figure 33. Asia Pacific Mitral Regurgitation Market Size Market Share by Application (2017-2028)
Figure 34. Asia Pacific Mitral Regurgitation Market Size Share by Region (2017-2028)
Figure 35. China Mitral Regurgitation Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Japan Mitral Regurgitation Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. South Korea Mitral Regurgitation Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Southeast Asia Mitral Regurgitation Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. India Mitral Regurgitation Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Australia Mitral Regurgitation Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 41. Latin America Mitral Regurgitation Market Size YoY (2017-2028) & (US$ Million)
Figure 42. Latin America Mitral Regurgitation Market Size Market Share by Type (2017-2028)
Figure 43. Latin America Mitral Regurgitation Market Size Market Share by Application (2017-2028)
Figure 44. Latin America Mitral Regurgitation Market Size Share by Country (2017-2028)
Figure 45. Mexico Mitral Regurgitation Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. Brazil Mitral Regurgitation Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. Middle East & Africa Mitral Regurgitation Market Size YoY (2017-2028) & (US$ Million)
Figure 48. Middle East and Africa Mitral Regurgitation Market Size Market Share by Type (2017-2028)
Figure 49. Middle East and Africa Mitral Regurgitation Market Size Market Share by Application (2017-2028)
Figure 50. Middle East and Africa Mitral Regurgitation Market Size Share by Country (2017-2028)
Figure 51. Turkey Mitral Regurgitation Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 52. Saudi Arabia Mitral Regurgitation Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 53. UAE Mitral Regurgitation Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. Edwards Lifesciences Revenue Growth Rate in Mitral Regurgitation Business (2017-2022)
Figure 55. Abbott Revenue Growth Rate in Mitral Regurgitation Business (2017-2022)
Figure 56. CardioSolution Revenue Growth Rate in Mitral Regurgitation Business (2017-2022)
Figure 57. NeoChord Revenue Growth Rate in Mitral Regurgitation Business (2017-2022)
Figure 58. Mitralign Revenue Growth Rate in Mitral Regurgitation Business (2017-2022)
Figure 59. Medtronic Revenue Growth Rate in Mitral Regurgitation Business (2017-2022)
Figure 60. Boston Scientific Revenue Growth Rate in Mitral Regurgitation Business (2017-2022)
Figure 61. Mitralix Revenue Growth Rate in Mitral Regurgitation Business (2017-2022)
Figure 62. Shanghai Hanyu Medical Technology Revenue Growth Rate in Mitral Regurgitation Business (2017-2022)
Figure 63. Valgen Holding Corporation Revenue Growth Rate in Mitral Regurgitation Business (2017-2022)
Figure 64. NeoChord Revenue Growth Rate in Mitral Regurgitation Business (2017-2022)
Figure 65. CoreMedic Revenue Growth Rate in Mitral Regurgitation Business (2017-2022)
Figure 66. Babic Chord Revenue Growth Rate in Mitral Regurgitation Business (2017-2022)
Figure 67. Gore Medical Revenue Growth Rate in Mitral Regurgitation Business (2017-2022)
Figure 68. Valtech Cardio Revenue Growth Rate in Mitral Regurgitation Business (2017-2022)
Figure 69. Transcardiac Revenue Growth Rate in Mitral Regurgitation Business (2017-2022)
Figure 70. ChoRe Revenue Growth Rate in Mitral Regurgitation Business (2017-2022)
Figure 71. AVVIE Revenue Growth Rate in Mitral Regurgitation Business (2017-2022)
Figure 72. Cardiovalve Revenue Growth Rate in Mitral Regurgitation Business (2017-2022)
Figure 73. HighLife SAS Revenue Growth Rate in Mitral Regurgitation Business (2017-2022)
Figure 74. Neovasc Revenue Growth Rate in Mitral Regurgitation Business (2017-2022)
Figure 75. MitrAssist Lifesciences Revenue Growth Rate in Mitral Regurgitation Business (2017-2022)
Figure 76. Shanghai NewMed Medical Revenue Growth Rate in Mitral Regurgitation Business (2017-2022)
Figure 77. Peijia Medical Revenue Growth Rate in Mitral Regurgitation Business (2017-2022)
Figure 78. MicroPort CardioFlow Medtech Revenue Growth Rate in Mitral Regurgitation Business (2017-2022)
Figure 79. Bottom-up and Top-down Approaches for This Report
Figure 80. Data Triangulation
Figure 81. Key Executives Interviewed